Resmed (RMD) Share-based Compensation (2009 - 2026)

Resmed's Share-based Compensation history runs 18 years deep, the most recent figure standing at $26.8 million for Q1 2026.

• Quarterly Share-based Compensation rose 7260.44% year-over-year to $26.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.5 million (down 13.27% YoY) and the FY2025 annual result came in at $18.1 million, down 77.46% from the prior year.
• Share-based Compensation was $26.8 million for Q1 2026 at Resmed, down from $28.9 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $71.8 million in Q2 2024 and bottomed at -$30.0 million in Q1 2024.
• A 5-year average of $14.0 million and a median of $16.0 million in 2022 frame the typical range for Share-based Compensation.
• Peak annual rise in Share-based Compensation reached 21411.38% in 2024, while the deepest fall reached 872.59% in 2024.
• Resmed's Share-based Compensation stood at $16.5 million in 2022, then soared by 131.57% to $38.1 million in 2023, then tumbled by 56.11% to $16.7 million in 2024, then surged by 72.93% to $28.9 million in 2025, then decreased by 7.42% to $26.8 million in 2026.
• Business Quant data shows RMD's Share-based Compensation at $26.8 million in Q1 2026, $28.9 million in Q4 2025, and $21.2 million in Q3 2025.